APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalable Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Industry Research

Inhalable Drug Delivery Devices Industry Research Report 2026

4 July 2026132 pages

Choose your research edition.

Industry ResearchInhalable Drug Delivery Devices Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalable Drug Delivery Devices Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Inhalable Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalable Drug Delivery Devices Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalable Drug Delivery Devices Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Inhalable Drug Delivery Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Inhalable Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Inhalable Drug Delivery Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Inhalable Drug Delivery Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Inhalable Drug Delivery Devices include Acorda Therapeutics Inc, Baxter International Inc, Bellerophon Therapeutics Inc, Canigma A.L LTD, Edixomed Ltd, IDTx Systems, Inc., Impel NeuroPharma Inc, Kanabo Research Ltd and Mallinckrodt Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Inhalable Drug Delivery Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Inhalable Drug Delivery Devices Market by Company

Acorda Therapeutics Inc

Baxter International Inc

Bellerophon Therapeutics Inc

Canigma A.L LTD

Edixomed Ltd

IDTx Systems, Inc.

Impel NeuroPharma Inc

Kanabo Research Ltd

Mallinckrodt Plc

Medical Developments International Ltd

Medspray BV

NeuroproteXeon Inc

Next Safety, Inc.

Nobilis Therapeutics Inc

Sandoz International GmbH

Vero biotech

Zambon

Inhalable Drug Delivery Devices Segment by Type

Nebulizers

Pressurized Metered Dose Inhalers (PMDIs)

Dry Powder Inhalers (DPIs)

Others

Inhalable Drug Delivery Devices Segment by Application

Hospital

Clinic

Others

Inhalable Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalable Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalable Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalable Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Inhalable Drug Delivery Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Inhalable Drug Delivery Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Inhalable Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Inhalable Drug Delivery Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Inhalable Drug Delivery Devices Sales (k units) of Manufacturers (2021-2026) Table 7. Global Inhalable Drug Delivery Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Inhalable Drug Delivery Devices Revenue of Manufacturers (2021-2026) Table 9. Global Inhalable Drug Delivery Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Inhalable Drug Delivery Devices Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Inhalable Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Inhalable Drug Delivery Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Inhalable Drug Delivery Devices, Product Type & Application Table 14. Global Inhalable Drug Delivery Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Inhalable Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Acorda Therapeutics Inc Company Information Table 19. Acorda Therapeutics Inc Business Overview Table 20. Acorda Therapeutics Inc Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Acorda Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio Table 22. Acorda Therapeutics Inc Recent Developments Table 23. Baxter International Inc Company Information Table 24. Baxter International Inc Business Overview Table 25. Baxter International Inc Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Baxter International Inc Inhalable Drug Delivery Devices Product Portfolio Table 27. Baxter International Inc Recent Developments Table 28. Bellerophon Therapeutics Inc Company Information Table 29. Bellerophon Therapeutics Inc Business Overview Table 30. Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio Table 32. Bellerophon Therapeutics Inc Recent Developments Table 33. Canigma A.L LTD Company Information Table 34. Canigma A.L LTD Business Overview Table 35. Canigma A.L LTD Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Canigma A.L LTD Inhalable Drug Delivery Devices Product Portfolio Table 37. Canigma A.L LTD Recent Developments Table 38. Edixomed Ltd Company Information Table 39. Edixomed Ltd Business Overview Table 40. Edixomed Ltd Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Edixomed Ltd Inhalable Drug Delivery Devices Product Portfolio Table 42. Edixomed Ltd Recent Developments Table 43. IDTx Systems, Inc. Company Information Table 44. IDTx Systems, Inc. Business Overview Table 45. IDTx Systems, Inc. Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. IDTx Systems, Inc. Inhalable Drug Delivery Devices Product Portfolio Table 47. IDTx Systems, Inc. Recent Developments Table 48. Impel NeuroPharma Inc Company Information Table 49. Impel NeuroPharma Inc Business Overview Table 50. Impel NeuroPharma Inc Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Impel NeuroPharma Inc Inhalable Drug Delivery Devices Product Portfolio Table 52. Impel NeuroPharma Inc Recent Developments Table 53. Kanabo Research Ltd Company Information Table 54. Kanabo Research Ltd Business Overview Table 55. Kanabo Research Ltd Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Kanabo Research Ltd Inhalable Drug Delivery Devices Product Portfolio Table 57. Kanabo Research Ltd Recent Developments Table 58. Mallinckrodt Plc Company Information Table 59. Mallinckrodt Plc Business Overview Table 60. Mallinckrodt Plc Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Mallinckrodt Plc Inhalable Drug Delivery Devices Product Portfolio Table 62. Mallinckrodt Plc Recent Developments Table 63. Medical Developments International Ltd Company Information Table 64. Medical Developments International Ltd Business Overview Table 65. Medical Developments International Ltd Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Medical Developments International Ltd Inhalable Drug Delivery Devices Product Portfolio Table 67. Medical Developments International Ltd Recent Developments Table 68. Medspray BV Company Information Table 69. Medspray BV Business Overview Table 70. Medspray BV Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Medspray BV Inhalable Drug Delivery Devices Product Portfolio Table 72. Medspray BV Recent Developments Table 73. NeuroproteXeon Inc Company Information Table 74. NeuroproteXeon Inc Business Overview Table 75. NeuroproteXeon Inc Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. NeuroproteXeon Inc Inhalable Drug Delivery Devices Product Portfolio Table 77. NeuroproteXeon Inc Recent Developments Table 78. Next Safety, Inc. Company Information Table 79. Next Safety, Inc. Business Overview Table 80. Next Safety, Inc. Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Next Safety, Inc. Inhalable Drug Delivery Devices Product Portfolio Table 82. Next Safety, Inc. Recent Developments Table 83. Nobilis Therapeutics Inc Company Information Table 84. Nobilis Therapeutics Inc Business Overview Table 85. Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio Table 87. Nobilis Therapeutics Inc Recent Developments Table 88. Sandoz International GmbH Company Information Table 89. Sandoz International GmbH Business Overview Table 90. Sandoz International GmbH Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Sandoz International GmbH Inhalable Drug Delivery Devices Product Portfolio Table 92. Sandoz International GmbH Recent Developments Table 93. Vero biotech Company Information Table 94. Vero biotech Business Overview Table 95. Vero biotech Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Vero biotech Inhalable Drug Delivery Devices Product Portfolio Table 97. Vero biotech Recent Developments Table 98. Zambon Company Information Table 99. Zambon Business Overview Table 100. Zambon Inhalable Drug Delivery Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Zambon Inhalable Drug Delivery Devices Product Portfolio Table 102. Zambon Recent Developments Table 103. Global Inhalable Drug Delivery Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Inhalable Drug Delivery Devices Sales by Region (2021-2026) & (k units) Table 105. Global Inhalable Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 106. Global Inhalable Drug Delivery Devices Sales by Region (2027-2032) & (k units) Table 107. Global Inhalable Drug Delivery Devices Sales Market Share by Region (2027-2032) Table 108. Global Inhalable Drug Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Inhalable Drug Delivery Devices Revenue Market Share by Region (2021-2026) Table 110. Global Inhalable Drug Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Inhalable Drug Delivery Devices Revenue Market Share by Region (2027-2032) Table 112. North America Inhalable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 114. North America Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 115. North America Inhalable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Inhalable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Inhalable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 119. Europe Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 120. Europe Inhalable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Inhalable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Inhalable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Inhalable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Inhalable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Inhalable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 129. South America Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 130. South America Inhalable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Inhalable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Inhalable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Inhalable Drug Delivery Devices Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Inhalable Drug Delivery Devices Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Inhalable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Inhalable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Inhalable Drug Delivery Devices Sales by Type (2021-2026) & (k units) Table 138. Global Inhalable Drug Delivery Devices Sales by Type (2027-2032) & (k units) Table 139. Global Inhalable Drug Delivery Devices Sales Market Share by Type (2021-2026) Table 140. Global Inhalable Drug Delivery Devices Sales Market Share by Type (2027-2032) Table 141. Global Inhalable Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Inhalable Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 144. Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 145. Global Inhalable Drug Delivery Devices Price by Type (2021-2026) & (USD/unit) Table 146. Global Inhalable Drug Delivery Devices Price by Type (2027-2032) & (USD/unit) Table 147. Global Inhalable Drug Delivery Devices Sales by Application (2021-2026) & (k units) Table 148. Global Inhalable Drug Delivery Devices Sales by Application (2027-2032) & (k units) Table 149. Global Inhalable Drug Delivery Devices Sales Market Share by Application (2021-2026) Table 150. Global Inhalable Drug Delivery Devices Sales Market Share by Application (2027-2032) Table 151. Global Inhalable Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Inhalable Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 154. Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 155. Global Inhalable Drug Delivery Devices Price by Application (2021-2026) & (USD/unit) Table 156. Global Inhalable Drug Delivery Devices Price by Application (2027-2032) & (USD/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Inhalable Drug Delivery Devices Distributors List Table 160. Inhalable Drug Delivery Devices Customers List Table 161. Inhalable Drug Delivery Devices Industry Trends Table 162. Inhalable Drug Delivery Devices Industry Drivers Table 163. Inhalable Drug Delivery Devices Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Inhalable Drug Delivery Devices Product Image Figure 5. Global Inhalable Drug Delivery Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Inhalable Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Inhalable Drug Delivery Devices Sales (2021-2032) & (k units) Figure 8. Global Inhalable Drug Delivery Devices Average Price (USD/unit) & (2021-2032) Figure 9. Nebulizers Product Image Figure 10. Pressurized Metered Dose Inhalers (PMDIs) Product Image Figure 11. Dry Powder Inhalers (DPIs) Product Image Figure 12. Others Product Image Figure 13. Hospital Product Image Figure 14. Clinic Product Image Figure 15. Others Product Image Figure 16. Global Inhalable Drug Delivery Devices Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Inhalable Drug Delivery Devices, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Inhalable Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Inhalable Drug Delivery Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Inhalable Drug Delivery Devices Sales by Region in 2025 Figure 22. Global Inhalable Drug Delivery Devices Revenue by Region in 2025 Figure 23. North America Inhalable Drug Delivery Devices Market Size by Country in 2025 Figure 24. North America Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 25. North America Inhalable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 26. United States Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Inhalable Drug Delivery Devices Market Size by Country in 2025 Figure 30. Europe Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 31. Europe Inhalable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 32. Germany Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Inhalable Drug Delivery Devices Market Size by Country in 2025 Figure 43. Asia Pacific Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Inhalable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 45. China Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Inhalable Drug Delivery Devices Market Size by Country in 2025 Figure 54. South America Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 55. South America Inhalable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 56. Brazil Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Inhalable Drug Delivery Devices Market Size by Country in 2025 Figure 60. Middle East and Africa Inhalable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Inhalable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 62. Egypt Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Inhalable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Inhalable Drug Delivery Devices Sales Market Share by Type (2021-2032) Figure 68. Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 69. Global Inhalable Drug Delivery Devices Price (USD/unit) by Type (2021-2032) Figure 70. Global Inhalable Drug Delivery Devices Sales Market Share by Application (2021-2032) Figure 71. Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 72. Global Inhalable Drug Delivery Devices Price (USD/unit) by Application (2021-2032) Figure 73. Inhalable Drug Delivery Devices Value Chain Figure 74. Inhalable Drug Delivery Devices Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Inhalable Drug Delivery Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Nebulizers
  • Pressurized Metered Dose Inhalers (PMDIs)
  • Dry Powder Inhalers (DPIs)
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Acorda Therapeutics Inc
  • Baxter International Inc
  • Bellerophon Therapeutics Inc
  • Canigma A.L LTD
  • Edixomed Ltd
  • IDTx Systems, Inc.
  • Impel NeuroPharma Inc
  • Kanabo Research Ltd
  • Mallinckrodt Plc
  • Medical Developments International Ltd
  • Medspray BV
  • NeuroproteXeon Inc
  • Next Safety, Inc.
  • Nobilis Therapeutics Inc
  • Sandoz International GmbH
  • Vero biotech
  • Zambon

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Inhalable Drug Delivery Devices Market Size (2021-2032)
  4. 2.2.2 Global Inhalable Drug Delivery Devices Sales (2021-2032)
  5. 2.2.3 Global Inhalable Drug Delivery Devices Market Average Price (2021-2032)
  6. 2.3 Inhalable Drug Delivery Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Nebulizers
  9. 2.3.3 Pressurized Metered Dose Inhalers (PMDIs)
  10. 2.3.4 Dry Powder Inhalers (DPIs)
  11. 2.3.5 Others
  12. 2.4 Inhalable Drug Delivery Devices by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Clinic
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Inhalable Drug Delivery Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Inhalable Drug Delivery Devices Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Inhalable Drug Delivery Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Inhalable Drug Delivery Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Inhalable Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Inhalable Drug Delivery Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Inhalable Drug Delivery Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Inhalable Drug Delivery Devices, Established Date
  9. 3.9 Global Inhalable Drug Delivery Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Acorda Therapeutics Inc
  2. 4.1.1 Acorda Therapeutics Inc Company Information
  3. 4.1.2 Acorda Therapeutics Inc Business Overview
  4. 4.1.3 Acorda Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Acorda Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
  6. 4.1.5 Acorda Therapeutics Inc Recent Developments
  7. 4.2 Baxter International Inc
  8. 4.2.1 Baxter International Inc Company Information
  9. 4.2.2 Baxter International Inc Business Overview
  10. 4.2.3 Baxter International Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Baxter International Inc Inhalable Drug Delivery Devices Product Portfolio
  12. 4.2.5 Baxter International Inc Recent Developments
  13. 4.3 Bellerophon Therapeutics Inc
  14. 4.3.1 Bellerophon Therapeutics Inc Company Information
  15. 4.3.2 Bellerophon Therapeutics Inc Business Overview
  16. 4.3.3 Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bellerophon Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
  18. 4.3.5 Bellerophon Therapeutics Inc Recent Developments
  19. 4.4 Canigma A.L LTD
  20. 4.4.1 Canigma A.L LTD Company Information
  21. 4.4.2 Canigma A.L LTD Business Overview
  22. 4.4.3 Canigma A.L LTD Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Canigma A.L LTD Inhalable Drug Delivery Devices Product Portfolio
  24. 4.4.5 Canigma A.L LTD Recent Developments
  25. 4.5 Edixomed Ltd
  26. 4.5.1 Edixomed Ltd Company Information
  27. 4.5.2 Edixomed Ltd Business Overview
  28. 4.5.3 Edixomed Ltd Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Edixomed Ltd Inhalable Drug Delivery Devices Product Portfolio
  30. 4.5.5 Edixomed Ltd Recent Developments
  31. 4.6 IDTx Systems, Inc.
  32. 4.6.1 IDTx Systems, Inc. Company Information
  33. 4.6.2 IDTx Systems, Inc. Business Overview
  34. 4.6.3 IDTx Systems, Inc. Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 IDTx Systems, Inc. Inhalable Drug Delivery Devices Product Portfolio
  36. 4.6.5 IDTx Systems, Inc. Recent Developments
  37. 4.7 Impel NeuroPharma Inc
  38. 4.7.1 Impel NeuroPharma Inc Company Information
  39. 4.7.2 Impel NeuroPharma Inc Business Overview
  40. 4.7.3 Impel NeuroPharma Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Impel NeuroPharma Inc Inhalable Drug Delivery Devices Product Portfolio
  42. 4.7.5 Impel NeuroPharma Inc Recent Developments
  43. 4.8 Kanabo Research Ltd
  44. 4.8.1 Kanabo Research Ltd Company Information
  45. 4.8.2 Kanabo Research Ltd Business Overview
  46. 4.8.3 Kanabo Research Ltd Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Kanabo Research Ltd Inhalable Drug Delivery Devices Product Portfolio
  48. 4.8.5 Kanabo Research Ltd Recent Developments
  49. 4.9 Mallinckrodt Plc
  50. 4.9.1 Mallinckrodt Plc Company Information
  51. 4.9.2 Mallinckrodt Plc Business Overview
  52. 4.9.3 Mallinckrodt Plc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mallinckrodt Plc Inhalable Drug Delivery Devices Product Portfolio
  54. 4.9.5 Mallinckrodt Plc Recent Developments
  55. 4.10 Medical Developments International Ltd
  56. 4.10.1 Medical Developments International Ltd Company Information
  57. 4.10.2 Medical Developments International Ltd Business Overview
  58. 4.10.3 Medical Developments International Ltd Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Medical Developments International Ltd Inhalable Drug Delivery Devices Product Portfolio
  60. 4.10.5 Medical Developments International Ltd Recent Developments
  61. 4.11 Medspray BV
  62. 4.11.1 Medspray BV Company Information
  63. 4.11.2 Medspray BV Business Overview
  64. 4.11.3 Medspray BV Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Medspray BV Inhalable Drug Delivery Devices Product Portfolio
  66. 4.11.5 Medspray BV Recent Developments
  67. 4.12 NeuroproteXeon Inc
  68. 4.12.1 NeuroproteXeon Inc Company Information
  69. 4.12.2 NeuroproteXeon Inc Business Overview
  70. 4.12.3 NeuroproteXeon Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 NeuroproteXeon Inc Inhalable Drug Delivery Devices Product Portfolio
  72. 4.12.5 NeuroproteXeon Inc Recent Developments
  73. 4.13 Next Safety, Inc.
  74. 4.13.1 Next Safety, Inc. Company Information
  75. 4.13.2 Next Safety, Inc. Business Overview
  76. 4.13.3 Next Safety, Inc. Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Next Safety, Inc. Inhalable Drug Delivery Devices Product Portfolio
  78. 4.13.5 Next Safety, Inc. Recent Developments
  79. 4.14 Nobilis Therapeutics Inc
  80. 4.14.1 Nobilis Therapeutics Inc Company Information
  81. 4.14.2 Nobilis Therapeutics Inc Business Overview
  82. 4.14.3 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Nobilis Therapeutics Inc Inhalable Drug Delivery Devices Product Portfolio
  84. 4.14.5 Nobilis Therapeutics Inc Recent Developments
  85. 4.15 Sandoz International GmbH
  86. 4.15.1 Sandoz International GmbH Company Information
  87. 4.15.2 Sandoz International GmbH Business Overview
  88. 4.15.3 Sandoz International GmbH Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Sandoz International GmbH Inhalable Drug Delivery Devices Product Portfolio
  90. 4.15.5 Sandoz International GmbH Recent Developments
  91. 4.16 Vero biotech
  92. 4.16.1 Vero biotech Company Information
  93. 4.16.2 Vero biotech Business Overview
  94. 4.16.3 Vero biotech Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Vero biotech Inhalable Drug Delivery Devices Product Portfolio
  96. 4.16.5 Vero biotech Recent Developments
  97. 4.17 Zambon
  98. 4.17.1 Zambon Company Information
  99. 4.17.2 Zambon Business Overview
  100. 4.17.3 Zambon Inhalable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Zambon Inhalable Drug Delivery Devices Product Portfolio
  102. 4.17.5 Zambon Recent Developments
5 Global Inhalable Drug Delivery Devices Market Scenario by Region
  1. 5.1 Global Inhalable Drug Delivery Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Inhalable Drug Delivery Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Inhalable Drug Delivery Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Inhalable Drug Delivery Devices Sales by Region: 2027-2032
  5. 5.3 Global Inhalable Drug Delivery Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Inhalable Drug Delivery Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Inhalable Drug Delivery Devices Revenue by Region: 2027-2032
  8. 5.4 North America Inhalable Drug Delivery Devices Market Facts & Figures by Country
  9. 5.4.1 North America Inhalable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Inhalable Drug Delivery Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Inhalable Drug Delivery Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Inhalable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Inhalable Drug Delivery Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Inhalable Drug Delivery Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Inhalable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Inhalable Drug Delivery Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Inhalable Drug Delivery Devices Market Facts & Figures by Country
  41. 5.7.1 South America Inhalable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Inhalable Drug Delivery Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Inhalable Drug Delivery Devices Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Inhalable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Inhalable Drug Delivery Devices Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Inhalable Drug Delivery Devices Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Inhalable Drug Delivery Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Inhalable Drug Delivery Devices Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Inhalable Drug Delivery Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Inhalable Drug Delivery Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Inhalable Drug Delivery Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Inhalable Drug Delivery Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Inhalable Drug Delivery Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Inhalable Drug Delivery Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Inhalable Drug Delivery Devices Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Inhalable Drug Delivery Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Inhalable Drug Delivery Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Inhalable Drug Delivery Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Inhalable Drug Delivery Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Inhalable Drug Delivery Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Inhalable Drug Delivery Devices Value Chain Analysis
  2. 8.1.1 Inhalable Drug Delivery Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Inhalable Drug Delivery Devices Production Mode & Process
  5. 8.2 Inhalable Drug Delivery Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Inhalable Drug Delivery Devices Distributors
  8. 8.2.3 Inhalable Drug Delivery Devices Customers
9 Global Inhalable Drug Delivery Devices Analyzing Market Dynamics
  1. 9.1 Inhalable Drug Delivery Devices Industry Trends
  2. 9.2 Inhalable Drug Delivery Devices Industry Drivers
  3. 9.3 Inhalable Drug Delivery Devices Industry Opportunities and Challenges
  4. 9.4 Inhalable Drug Delivery Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst